What is the best antidepressant to combine with duloxetine (Cymbalta) for treating depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combining Antidepressants with Duloxetine for Depression Treatment

Mirtazapine is the best antidepressant to combine with duloxetine (Cymbalta) for treating depression due to its complementary mechanism of action and potential for enhanced efficacy through different neurotransmitter pathways.

Rationale for Combining Antidepressants

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by inhibiting the reuptake of both serotonin and norepinephrine 1. When monotherapy with duloxetine is insufficient, adding a second antidepressant with a different mechanism of action may provide additional benefit for patients with treatment-resistant depression.

Why Mirtazapine with Duloxetine?

  1. Complementary Mechanisms:

    • Duloxetine: SNRI affecting serotonin and norepinephrine reuptake
    • Mirtazapine: Noradrenergic and specific serotonergic antidepressant (NaSSA) affecting α2-adrenergic, 5-HT2, 5-HT3, H1-histamine, 5-HT1A, and α1-adrenergic receptors 2
  2. Synergistic Benefits:

    • Mirtazapine has a faster onset of action compared to SSRIs like citalopram, fluoxetine, paroxetine, or sertraline 1
    • The combination addresses multiple neurotransmitter systems simultaneously
    • Mirtazapine's sedating properties can help with sleep disturbances common in depression 2
  3. Evidence for Combination Therapy:

    • The American Psychiatric Association suggests that mirtazapine may be combined with other antidepressants for enhanced efficacy in treatment-resistant depression 2
    • Pooled analyses suggest that dual-acting agents like SNRIs combined with medications affecting different receptors may provide better outcomes 1

Dosing and Administration

  • Duloxetine: Maintain at 40-80 mg daily, preferably split into two doses 3
  • Mirtazapine: Start at 7.5-15 mg at bedtime, with gradual titration every 5-7 days to a maximum therapeutic dose of 30-45 mg 2
  • Monitoring: Schedule follow-up within 2 weeks of initiating combination therapy 2

Potential Advantages Over Other Combinations

  1. Compared to SSRI combinations:

    • Duloxetine already addresses both serotonin and norepinephrine pathways, making additional SSRIs (like fluoxetine, paroxetine, or escitalopram) potentially redundant 4
    • Evidence suggests that duloxetine has similar efficacy to SSRIs but with potential advantages for pain symptoms 5
  2. Compared to other SNRIs:

    • Adding venlafaxine would be mechanistically redundant as both are SNRIs 4
    • Mirtazapine offers a different mechanism of action that complements duloxetine
  3. Compared to tricyclic antidepressants:

    • TCAs have higher side effect burden and toxicity in overdose compared to mirtazapine 1, 2
    • Mirtazapine has a better safety profile in overdose than TCAs 2

Monitoring and Safety Considerations

  1. Watch for additive sedation:

    • Both medications can cause sedation; warn patients about driving or operating machinery 2
    • Morning dosing of duloxetine and evening dosing of mirtazapine may help manage sedation
  2. Monitor for:

    • Excessive sedation and cognitive impairment
    • Cardiovascular effects, especially orthostatic hypotension
    • Signs of serotonin syndrome (though risk is lower with mirtazapine than with other serotonergic agents)
    • Weight gain and metabolic changes (both medications can increase appetite) 2
  3. Contraindications:

    • Avoid in patients with severe hepatic impairment
    • Do not use with MAO inhibitors
    • Use caution in patients with angle-closure glaucoma or seizure history 2

Treatment Duration

For patients with major depressive disorder, the American College of Physicians recommends:

  • First episode: Continue treatment for 4-9 months after satisfactory response
  • Two or more episodes: Longer duration therapy is beneficial 2
  • When discontinuing: Gradual tapering over 10-14 days to minimize withdrawal symptoms 2

Alternative Options

If mirtazapine is not tolerated or contraindicated, bupropion could be considered as an alternative combination with duloxetine, as it has a different mechanism of action (dopamine and norepinephrine reuptake inhibition) and may have advantages regarding sexual dysfunction 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Management for Depression and Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005

Research

Duloxetine versus other anti-depressive agents for depression.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.